MedPath

Comparison of two drugs for control of bleeding after vaginal delivery,in one arm drug named carbetocin alone and in other arm combination of carbetocin with methergine.

Phase 4
Conditions
Health Condition 1: O720- Third-stage hemorrhage
Registration Number
CTRI/2024/03/064722
Lead Sponsor
Dr Fathima najeeb
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

WOMEN EXPECTED TO GIVE BIRTH VAGINALLY

TERM GESTATION

PRIMI AND MUTIGRAVIDA

MUTIPLE PREGNANCIES

RECIEVING ALL MODE OF ANALGESIA

Exclusion Criteria

PRETERM AND POST DATED PREGNANCIES

WOMEN UNDERGOING CAESAREAN SECTION

ABRUPTIO PLACENTA AND PLACENTA PREVIA

GESTATIONAL HYPERTENSION AND CHRONIC HYPERTENSION

ABNORMAL LIE

KNOWN CASE OF EPILEPSY CARDIAC AND RESPIRATORY DISORDERS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COMPARE MEAN BLOOD LOSS IN BOTH GROUPS <br/ ><br>USE OF ADDITIONAL UTEROTONICS <br/ ><br>OCCURANCE OF POSTPARTUM HEMORRHAGE <br/ ><br>REQUIREMENT OF BLOOD TRASFUSION <br/ ><br>HEMOGLOBIN DROP <br/ ><br>Timepoint: FROM TIME OF DELIVERY TO POST NATAL DAY 2 <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
BLOOD PRESSURE <br/ ><br>PULSE <br/ ><br>SIDE EFFECTS OF <br/ ><br>NAUSEA <br/ ><br>VOMITING <br/ ><br>HYPOTENSION <br/ ><br>RETAINED PLACENTATimepoint: 1 HOUR
© Copyright 2025. All Rights Reserved by MedPath